Related Experiment Video
Updated: May 14, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Management of myopericarditis
Massimo Imazio1, Leslie T Cooper
1Department of Cardiology, Maria Vittoria Hospital, Via Luigi Cibrario 72, Torino 10141, Italy. massimo_imazio@yahoo.it
Abstract:
Myopericarditis is a primarily pericardial inflammatory syndrome occurring when clinical diagnostic criteria for pericarditis are satisfied and concurrent mild myocardial involvement is documented by elevation of biomarkers of myocardial damage (i.e., increased troponins). Limited clinical data on the causes of myopericarditis suggest that viral infections are among the most common causes in developed countries. Cardiotropic viruses can cause pericardial and myocardial inflammation via direct cytolytic or cytotoxic effects and/or subsequent immune-mediated mechanisms. Many cases of myopericarditis are subclinical. In other patients, cardiac symptoms and signs are overshadowed by systemic manifestations of infection or inflammation. The increased sensitivity of troponin assays and contemporary widespread use of troponins has greatly increased the reported number of cases. Management is similar to that reported for pericarditis, generally with a reduction of empiric anti-inflammatory doses mainly aimed at the control of symptoms. Rest and avoidance of physical activity beyond normal sedentary activities has been recommended for 6 months, is recommended as for myocarditis. At present, there is no evidence that troponin elevation confers worse prognosis (i.e., a greater risk of recurrence, death or transplantation) in patients with preserved left ventricular function. Usually complete remission is seen in 3-6 months.
Insights
Myopericarditis, an inflammation of the heart lining and muscle, is often caused by viral infections. Elevated troponins indicate mild heart muscle involvement, but typically do not worsen the prognosis in patients with normal heart function.
Area of Science:
- Cardiology
- Infectious Diseases
- Inflammatory Syndromes
Background:
- Myopericarditis is an inflammatory heart condition involving both the pericardium and myocardium.
- Viral infections are a leading cause of myopericarditis in developed nations.
- Increased sensitivity of troponin assays has led to more frequent diagnoses.
Purpose of the Study:
- To review the causes, clinical presentation, and management of myopericarditis.
- To assess the prognostic significance of troponin elevation in myopericarditis.
- To understand the typical recovery course for patients with myopericarditis.
Main Methods:
- Review of clinical data and diagnostic criteria for myopericarditis.
- Analysis of the role of cardiotropic viruses in causing inflammation.
- Evaluation of management strategies and prognostic factors, including troponin levels.
Main Results:
- Myopericarditis is characterized by pericarditis criteria and elevated myocardial damage biomarkers (troponins).
- Viral etiologies are common, acting through direct or immune-mediated pathways.
- Elevated troponins in patients with preserved left ventricular function do not appear to indicate a worse prognosis.
- Complete remission is typically observed within 3-6 months.
Conclusions:
- Myopericarditis management mirrors pericarditis treatment, focusing on symptom control with anti-inflammatory agents.
- A 6-month period of rest is recommended, similar to myocarditis guidelines.
- Troponin elevation in this context does not predict adverse outcomes, and most patients achieve full recovery.
Related Concept Videos
Myocarditis III: Medical Management
Pericarditis III: Medical Management
Pericarditis IV: Nursing Management
Endocarditis III: Medical Management
Myocarditis IV: Nursing Management
Cardiomyopathy V: Interprofessional Care
